Law360, Philadelphia (October 11, 2012, 3:19 PM ET) -- A member of a nationwide class that agreed to settle multidistrict federal fen-phen litigation can pursue product liability claims in Pennsylvania state court after a judge there on Wednesday refused to stay an upcoming trial while drugmakers, including Wyeth Pharmaceuticals Inc., pursue an appeal.
Wyeth, a defendant in the suit along with Pfizer Inc., had asked the Philadelphia Court of Common Pleas to stay the trial while the companies petitioned the Third Circuit to overturn a federal court’s decision refusing to grant an injunction preventing the...
Wyeth Loses Bid For Stay In Philly Fen-Phen Trial
To view the full article, take a free trial now.
